MilliporeSigma’s Niko Kotsaftis Wins Future Leader Award by World Sustainability Awards 2025
NORTHAMPTON, MA / ACCESS Newswire / October 23, 2025 / Niko Kotsaftis, Energy & Sustainability Program Manager at MilliporeSigma, the...
Day: October 23, 2025
The Gourmet Gifts Expands 2025 Corporate & Holiday Gifting Collection
Canada's one-of-a-kind gift basket brand expands personalized presents for corporate and individual customers ahead of the holiday season.Toronto, Ontario--(Newsfile Corp....
MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions
NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter...
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell...
VSee Health Strengthens Balance Sheet With The Elimination of Debt
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 23, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering force in telehealth...
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide – Unleashing the Next Era of Clinical Trial Intelligence
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational...
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’s “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways...
Moderna to Host Investor Event – Analyst Day
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its...
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's...
Synfini Selected for SLAS 2026 Innovation AveNEW Showcase
Company Selected to Demonstrate its Novel AI Foundry That Unites Virtual and Physical Chemistry, Reducing the Time and Cost of...
Visory Health Partners with Albertsons Companies to Expand Access to Affordable Prescriptions Nationwide
The health tech company adds more than 1,700 Albertsons Cos. pharmacies to its partnership base of over 37,000 locationsESTERO, Fla.,...
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10...
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence...
Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG
Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent...
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA...
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery...